Accès gratuit
| Numéro |
Med Sci (Paris)
Volume 36, Octobre 2020
Les jeunes contre le cancer : la Ligue en soutien
|
|
|---|---|---|
| Page(s) | 42 - 46 | |
| DOI | https://doi.org/10.1051/medsci/2020197 | |
| Publié en ligne | 14 octobre 2020 | |
- Shang S, Hua F, Hu ZW. The regulation of beta-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 2017 ; 8 : 33972–33989. [CrossRef] [PubMed] [Google Scholar]
- Lhoumeau AC, Martinez S, Boher JM, et al. Overexpression of the promigratory and prometastatic PTK7 receptor is associated with an adverse clinical outcome in colorectal cancer. PLoS One 2015 ; 10 : e0123768. [CrossRef] [PubMed] [Google Scholar]
- Daulat AM, Borg JP. Wnt/planar cell polarity signaling: new opportunities for cancer treatment. Trends Cancer 2017 ; 3 : 113–125. [CrossRef] [PubMed] [Google Scholar]
- Peradziryi H, Tolwinski NS, Borchers A. The many roles of PTK7: a versatile regulator of cell-cell communication. Arch Biochem Biophys 2012 ; 524 : 71–76. [CrossRef] [PubMed] [Google Scholar]
- Martinez S, Scerbo P, Giordano M, et al. The PTK7 and ROR2 protein receptors interact in the vertebrate WNT/planar cell polarity (PCP) pathway. J Biol Chem 2015 ; 290 : 30562–30572. [CrossRef] [PubMed] [Google Scholar]
- Puppo F, Thome V, Lhoumeau AC, et al. Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling. EMBO Rep 2011 ; 12 : 43–49. [PubMed] [Google Scholar]
- Lu X, Borchers AG, Jolicoeur C, et al. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 2004 ; 430 : 93–98. [CrossRef] [PubMed] [Google Scholar]
- Lin Y, Zhang LH, Wang XH, et al. PTK7 as a novel marker for favorable gastric cancer patient survival. J Surg Oncol 2012 ; 106 : 880–886. [Google Scholar]
- Prebet T, Lhoumeau AC, Arnoulet C, et al. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. Blood 2010 ; 116 : 2315–2323. [Google Scholar]
- Ataseven B, Angerer R, Kates R, et al. PTK7 expression in triple-negative breast cancer. Anticancer Res 2013 ; 33 : 3759–3763. [PubMed] [Google Scholar]
- Meng L, Sefah K, O’Donoghue MB, et al. Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway. PLoS One 2010 ; 5 : e14018. [CrossRef] [PubMed] [Google Scholar]
- Damelin M, Bankovich A, Bernstein J, et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci Transl Med 2017; 9. [Google Scholar]
- Kung JE, Jura N. Prospects for pharmacological targeting of pseudokinases. Nat Rev Drug Discov 2019 ; 18 : 501–526. [PubMed] [Google Scholar]
- Liu M, Ma W, Li Q, et al. Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours. Cell Prolif 2019 ; 52 : e12511. [CrossRef] [PubMed] [Google Scholar]
- Karvonen H, Perttila R, Niininen W, et al. Targeting Wnt signaling pseudokinases in hematological cancers. Eur J Haematol 2018 ; 101 : 457–465. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.